We are live on ! Find out more
TBXU

Direxion Daily Biotech Top 5 Bull 2X ETF
TBXU

3 hedge funds and large institutions have $2.05M invested in Direxion Daily Biotech Top 5 Bull 2X ETF in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6.63% more ownership

Funds ownership: 58.65% → 65.27% (+6.6%)

0% more funds holding

Funds holding: 3 → 3 (0)

10% less capital invested

Capital invested by funds: $2.28M → $2.05M (-$230K)

44% less call options, than puts

Call options by funds: $46.1M | Put options by funds: $83M

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
$46.1M
Puts
$83M
Net Calls
-$36.9M
Net Calls Change
-$36.9M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GS
GTS Securities
New York
-$265K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$784K – – –
Bank of America
2
Bank of America
North Carolina
$784K – – –
GS
3
GTS Securities
New York
$479K -$265K -8,036 -34%

TBXU Hedge Fund Activity: Q1 2026 in Review

3 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) for Q1 2026, worth a combined $2.05M — down 10% from $2.28M a quarter earlier.

Fund positioning in TBXU was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was GTS Securities, cutting an estimated $265K.

  • 3 institutional investors held Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $2.05M of Direxion Daily Biotech Top 5 Bull 2X ETF stock for Q1 2026, down 10% quarter-over-quarter.
  • 0 funds opened new Direxion Daily Biotech Top 5 Bull 2X ETF positions in Q1 2026 and 0 closed out.
  • The largest Direxion Daily Biotech Top 5 Bull 2X ETF seller in Q1 2026 was GTS Securities, an estimated $265K sold.

Based on aggregated 13F filings for Q1 2026.